Selecting effective long-term treatment for bipolar patients: Monotherapy and combinations

Journal of Clinical Psychiatry

Volumn 64, Issue SUPPL. 5, 2003, Pages 53-61

  Grof, Paul ^a  

^a ROYAL OTTAWA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOZAPINE; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE; VALPROATE SEMISODIUM;

ALCOHOLISM; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DATA ANALYSIS; DISEASE COURSE; DRUG MIXTURE; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FAMILY HISTORY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MOOD DISORDER; PANIC; PATIENT SELECTION; POLYPHARMACY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE; TREATMENT FAILURE;

ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; COMORBIDITY; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM; LONG-TERM CARE; PIRENZEPINE; TREATMENT OUTCOME; TRIAZINES;

EID: 0038642170     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Bipolar Disorder. Am J Psychiatry 1994;151(suppl 12):1-36
2. Sachs GS, Printz DJ, Kahn DA, et al. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med April 2000
3. Brodie MJ, Yuen AW, for the 105 Study Group. Lamotrigine substitution study: evidence for synergism with sodium valproate? Epilepsy Res 1997;26:423-432
4. Angst J, Grof P. The course of monopolar depressions and bipolar psychoses. In: Villeneuve A, ed. Lithium in Psychiatry, a Synopsis. Quebec City, Quebec, Canada: Universite de Laval Press; 1976:93-104
5. Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of out-patients with bipolar I disorder. Arch Gen Psychiatry 2000;57:481-489
6. Greil W, Ludwig-Mayerhofer W, Erazo N, et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders: a randomized study. J Affect Disord 1997;43:151-161
7. Jenicek M. Clinical Case Reporting in Evidence-Based Medicine. 2nd ed. New York, NY: Oxford University Press Inc; 2001
8. Schou M, Thomsen K. Lithium prophylaxis of recurrent endogenous affective disorders. In: Johnson FN, ed. Lithium Research and Therapy. New York, NY: Academic Press; 1975:63-84
9. Grof P. Designing long-term clinical trials in affective disorders. J Affect Disord 1994;30:243-255
10. Calabrese JR, Suppes T, Bowden CL, et al, for the Lamictal 614 Study Group. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid cycling bipolar disorder. J Clin Psychiatry 2000;61:841-850
11. Calabrese J, Bowden C, DeVeaugh-Geiss J. Lamotrigine demonstrates long-term mood stabilization in recently manic patients. In: New Research Abstracts of the 154th Annual Meeting of the American Psychiatric Association; May 8, 2001; New Orleans, La. Abstract NR403:110
12. Calabrese JR, Shelton MD, Rapport DJ. Bipolar disorders and the effectiveness of novel anticonvulsants. J Clin Psychiatry 2002;63(suppl 3):5-9
13. Tohen M, Baker RW, Altshuler L, et al. Olanzapine versus divalproex sodium for bipolar mania: a 47-week study [abstract]. Eur Psychiatry 2002;17(suppl 1):109
14. Tohen M, Chengappa KNR, Suppes T, et al. Olanzapine cotherapy in prevention of recurrence in bipolar disorder [abstract]. Eur Psychiatry 2002;17 (suppl 1):109
15. Sanger TM, Grundy SL, Gibson PJ, et al. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. J Clin Psychiatry 2001;62:273-281
16. Schou M. Perspectives on lithium treatment of bipolar disorder: action, efficacy, effect on suicidal behavior. Bipolar Disord 1999;1:5-10
17. Schou M. Forty years of lithium treatment. Arch Gen Psychiatry 1997;54:9-13
18. Grof P, Hux M, Grof E, et al. Prediction of response to stabilizing lithium treatment. Pharmacopsychiatry 1983;16:195-200
19. Grof P, Alda M, Grof E, et al. The challenge of predicting response to stabilizing lithium treatment: the importance of patient selection. Br J Psychiatry 1993;163(suppl 21):16-19
20. Passmore MJ, Garnham J, Duffy A, et al. Phenotypic spectra of bipolar disorder in responders to lithium and lamotrigine. Presented at the 51st annual meeting of the Canadian Psychiatric Association; Nov 15-18, 2001; Montreal, Quebec, Canada
21. Grof P. Misconceptions about combination treatment for bipolar disorder. Presented at Lithium in Combination With Other Agents to Treat Bipolar Disorder; May 10, 2002; Washington, DC
22. Grof P, Duffy A, Cavazzoni P, et al. Is response to prophylactic lithium a familial trait? J Clin Psychiatry 2002;63:942-947
23. Greil W, Kleindienst N, Erazo N, et al. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol 1998;18:455-460
24. Tohen M, Jacobs TG, Grundy SL, et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2000;57:841-849
25. Suppes T, Webb A, Paul B, et al. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatmentresistant illness and a history of mania. Am J Psychiatry 1999;156:1164-1169
26. Grof P. Lithium update: selected issues. In: Ayd F, Taylor JT, Taylor BT, eds. Affective Disorders Reassessed. Baltimore, Md: Ayd Medical Communications; 1983:1-15
27. Bowden CL, Brugger AM, Swann AC, et al, for the Depakote Mania Study Group. Efficacy of divalproex versus lithium and placebo in the treatment of mania. JAMA 1994;271:918-924
28. Tohen M, Chengappa KNR, Suppes T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002;59:62-69
29. Berghöfer A, Kossmann B, Müller-Oerlinghausen B. Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years. Acta Psychiatr Scand 1996;93:349-354
30. Maj M, Pirozzi R, Kemali D. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology (Berl) 1989;98:535-538
31. Tondo L, Baldessarini RJ, Hennen J, et al. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry 1998;155:638-645
32. Grof P. Excellent lithium responders: people whose lives have been changed by lithium prophylaxis. In: Birch NJ, Gallicchio VS, Becker RW, eds. Lithium: 50 Years of Psychopharmacology. Cheshire, Conn: Weidner Publishing Group; 1999:36-51
33. Baldessarini RJ, Tondo L. Does lithium treatment still work? evidence of stable responses over three decades. Arch Gen Psychiatry 2000;57:187-190
34. Baldessarini RJ, Tondo L, Hennen J, et al. Is lithium still worth using? an update of selected recent research. Harv Rev Psychiatry 2002;10:59-75
35. Rybakowski JK, Chlopocka-Wozniak M, Suwalska A. The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disord 2001;3:63-67
36. Post RM, Ketter TA, Pazzaglia PJ, et al. Rational polypharmacy in the bipolar affective disorders. Epilepsy Res 1996;26(suppl 11):153-180
37. Post RM, Frye MA, Leverich GS, et al. The role of complex combination therapy in the treatment of refractory bipolar illness. Int J Neuropsychiatr Med 1998;3:66-86
38. Pande AC. Combination treatment in bipolar disorder [abstract]. Bipolar Disord 1999;1(suppl 1):17
39. Frye MA. The increasing use of polypharmacy for refractory mood disorders: twenty-five years of study. In: New Research Program and Abstracts of the 149th Annual Meeting of the American Psychiatric Association; May 7, 1996; New York, NY. Abstract NR312:151-152
40. Garnham J, Munro A, Teehan A, et al. Bipolar disorder: assessing treatment response in a naturalistic setting [abstract]. J Bipolar Disord 2001;3 (suppl 1):37